[SGMO] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
28-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 116.68%
YoY- 124.41%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 57,763 21,553 13,076 54,851 21,958 17,548 8,071 270.04%
PBT -1,271 -35,965 -42,974 4,501 -27,361 -30,356 -42,203 -90.25%
Tax 237 -36 -61 179 -54 -72 -53 -
NP -1,550 -35,929 -42,913 4,555 -27,307 -30,284 -42,150 -88.87%
Tax Rate - - - -3.98% - - - -
Total Cost 59,313 57,482 55,989 50,296 49,265 47,832 50,221 11.69%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -2.68 -166.70 -328.18 8.30 -124.36 -172.58 -522.24 -96.99%
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -0.01 -0.26 -0.37 0.04 -0.24 -0.26 -0.41 -91.53%
EPS Diluted -0.01 -0.26 -0.37 0.04 -0.24 -0.26 -0.41 -91.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.